Micah Zielke, CPA
Executive Director Finance at Labcorp Drug Development
Professional Overview
Micah Zielke is an experienced finance executive with a proven track record of driving strategic initiatives and operational excellence. As the Executive Director of Finance at Labcorp Drug Development, he leverages his expertise in financial management, data analysis, and process optimization to support the organization's success in the pharmaceutical and life sciences industry.
Experience Summary
Current Role
In his current role as Executive Director of Finance at Labcorp Drug Development, Micah is responsible for overseeing the company's financial operations, including budgeting, forecasting, and reporting. He collaborates closely with cross-functional teams to identify and implement cost-saving measures, enhance financial controls, and ensure the efficient utilization of resources. Micah's leadership and strategic vision have contributed to Labcorp's continued growth and profitability.
Career Progression
Prior to his current role, Micah held progressive finance positions at leading healthcare organizations, including serving as the Finance Manager at Pfizer and the Senior Financial Analyst at Merck. Throughout his career, he has demonstrated a strong aptitude for problem-solving, data-driven decision-making, and aligning financial strategies with broader business objectives.
Academic Background
Micah holds a Bachelor of Science in Accounting from the University of Wisconsin-Madison, where he graduated with honors. He is a Certified Public Accountant (CPA) and has completed executive leadership programs at the Wharton School of the University of Pennsylvania.
Areas of Expertise
- Financial management and strategic planning
- Cost optimization and process improvement
- Financial modeling and data analysis
- Budgeting, forecasting, and reporting
- Cross-functional collaboration and stakeholder management
- Regulatory compliance and risk management
Professional Impact
Under Micah's leadership, Labcorp Drug Development has achieved significant cost savings through the implementation of streamlined financial processes and the adoption of data-driven decision-making. He has played a pivotal role in enhancing the company's financial reporting capabilities, enabling executives to make more informed strategic decisions. Micah's contributions have been instrumental in supporting Labcorp's growth and maintaining its position as a leading provider of drug development services.
Conclusion
With his extensive finance expertise, strategic mindset, and commitment to operational excellence, Micah Zielke is well-positioned to continue driving Labcorp Drug Development's financial success and contribute to the organization's long-term growth and industry impact.
